Letter to the Editor From Chatelain et al: “Weekly Somapacitan Is Effective and Well Tolerated in Children With GH Deficiency: The Randomized Phase 3 REAL4 Trial”

Detalles Bibliográficos
Autores principales: Chatelain, Pierre, Kjelgaard-Hansen, Mads, Sprogøe, Kennett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348463/
https://www.ncbi.nlm.nih.gov/pubmed/36869710
http://dx.doi.org/10.1210/clinem/dgad096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348463/
https://www.ncbi.nlm.nih.gov/pubmed/36869710
http://dx.doi.org/10.1210/clinem/dgad096

Ejemplares similares